592P Bipolar androgen therapy (BAT) plus olaparib in men with metastatic castration-resistant prostate cancer (mCRPC)

Androgen Therapy ◽

Molecular and Clinical Characterization of Patients with Metastatic Castration Resistant Prostate Cancer Achieving Deep Responses to Bipolar Androgen Therapy

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2021.08.001 ◽

2021 ◽

Author(s):

Mark C. Markowski ◽

Sushant Kachhap ◽

Angelo M. De Marzo ◽

Laura A. Sena ◽

Jun Luo ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Therapy ◽

Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer

The Prostate ◽

10.1002/pros.23955 ◽

2020 ◽

Vol 80 (5) ◽

pp. 407-411

Author(s):

Mark C. Markowski ◽

Eugene Shenderov ◽

Mario A. Eisenberger ◽

Sushant Kachhap ◽

Drew M. Pardoll ◽

...

Keyword(s):

Prostate Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Blockade ◽

Checkpoint Blockade ◽

Androgen Therapy ◽

Castration Resistant ◽

Extreme Responses

Faculty Opinions recommendation of Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732320563.793553396 ◽

2018 ◽

Author(s):

Michael Glode

Keyword(s):

Prostate Cancer ◽

Phase 2 ◽

Open Label ◽

Androgen Therapy ◽

Castration Resistant ◽

Open Label Phase

Abstract 1114: Combining anti-androgen therapy and PARP inhibition results in synergistic cytotoxicity of metastatic castration-resistant prostate cancer (mCRPC) cells

10.1158/1538-7445.am2017-1114 ◽

2017 ◽

Author(s):

Sahithi Pamarthy ◽

Vinay Sagar ◽

Rajita J. Vatapalli ◽

Zachary Reinstein ◽

Muhammad Zayd Ansari ◽

...

Keyword(s):

Prostate Cancer ◽

Parp Inhibition ◽

Androgen Therapy ◽

Castration Resistant ◽

Synergistic Cytotoxicity

Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: Results from a pilot clinical study

Science Translational Medicine ◽

10.1126/scitranslmed.3010563 ◽

2015 ◽

Vol 7 (269) ◽

pp. 269ra2-269ra2 ◽

Cited By ~ 109

Author(s):

M. T. Schweizer ◽

E. S. Antonarakis ◽

H. Wang ◽

A. S. Ajiboye ◽

A. Spitz ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Study ◽

Androgen Therapy ◽

Castration Resistant ◽

Pilot Clinical Study ◽

Asymptomatic Men

434 Bipolar androgen therapy for men with castration sensitive and castration resistant prostate cancer: Reversing resistance and maintaining sensitivity to androgen ablative therapies

European Journal of Cancer ◽

10.1016/s0959-8049(14)70560-x ◽

2014 ◽

Vol 50 ◽

pp. 143

Author(s):

S.R. Denmeade ◽

E.S. Antonarakis ◽

M.A. Eisenberger ◽

M.A. Carducci ◽

H. Wang ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Therapy ◽

Ablative Therapies ◽

Re: Effect of Bipolar Androgen Therapy for Asymptomatic Men with Castration-resistant Prostate Cancer: Results from a Pilot Clinical Study

European Urology ◽

10.1016/j.eururo.2015.05.028 ◽

2015 ◽

Vol 68 (3) ◽

pp. 538-539 ◽

Cited By ~ 3

Author(s):

Nathan Wilken ◽

Jason M. Scovell ◽

Ranjith Ramasamy

Keyword(s):

Prostate Cancer ◽

Clinical Study ◽

Androgen Therapy ◽

Castration Resistant ◽

Pilot Clinical Study ◽

Asymptomatic Men

Anti-androgen Therapy Induces Transcriptomic Reprogramming in Metastatic Castration-Resistant Prostate Cancer in a Murine Model

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ◽

10.1016/j.bbadis.2021.166151 ◽

2021 ◽

pp. 166151

Author(s):

Yun Zhao ◽

Xiaoxia Peng ◽

Hope Baldwin ◽

Chao Zhang ◽

Zhongmin Liu ◽

...

Keyword(s):

Prostate Cancer ◽

Murine Model ◽

Androgen Therapy ◽

Identification of favorable subgroups for alternative anti‑androgen therapy in castration‑resistant prostate cancer

Molecular and Clinical Oncology ◽

10.3892/mco.2019.1915 ◽

2019 ◽

Author(s):

Kotaro Suzuki ◽

Tomoaki Terakawa ◽

Katsumi Shigemura ◽

Junya Furukawa ◽

Kenichi Harada ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Therapy ◽

New horizons for treating castration resistant prostate cancer: Bipolar Androgen Therapy

Brazilian Journal of Oncology ◽

10.5935/1806-6054.20180003 ◽

2018 ◽

Author(s):

Pedro Isaacsson Velho ◽

Katia Regina Marchetti ◽

Gabriel Passos Souza

Keyword(s):

Prostate Cancer ◽

Androgen Therapy ◽

New Horizons ◽